
Genetic Technologies for Hemophilia
Explore the science behind genetic technologies for hemophilia in this four-part video series from the WFH. Learn the basics of
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Format: Video
Listen to this 60-minute interactive webinar presented on 11 December 2020 to explore patient perspectives related to scientific inquiry of gene therapy.
The session was moderated by David Page (Canadian Hemophilia Society).
The panelists included Glenn Pierce, MD, PhD (WFH Vice President, Medical), Radoslaw Kaczmarek, PhD (Polish Hemophilia Society), Brian O’Mahony (Irish Haemophilia Society), and Mark W. Skinner (National Hemophilia Foundation).
To download a PDF of the slides on the webinar click the icon below.

Explore the science behind genetic technologies for hemophilia in this four-part video series from the WFH. Learn the basics of

The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the

This document is an introductory guide for people with hemophilia who wish to join the World Federation of Hemophilia (WFH)

This document is an introductory guide for people with hemophilia who wish to join the World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) Gene Therapy Registry (GTR) welcomes the participation of all Hemophilia Treatment Centres (HTCs) involved

The World Federation of Hemophilia (WFH) Gene Therapy Registry (GTR) welcomes the participation of all Hemophilia Treatment Centres (HTCs) involved